Featured News

New research from Tampere University in Finland shows exciting progress in a new drug for celiac disease. This drug, ZED1227 could be used alongside a gluten-free diet to help manage…

A new international study published in the journal Gastroenterology sheds light on the extensive economic burden of celiac disease. In addition to the cost of gluten-free  foods, the authors address…

A new study from researchers at Penn State College of Medicine reveals significant differences in micronutrient deficiencies and healthcare utilization among minority patients with celiac disease (CeD) compared to their…

The future of celiac disease research is promising, with exciting advancements in diagnosis and therapies presented at the 2024 Digestive Disease Week® (DDW) conference in Washington, D.C. Read on for updates the Celiac Disease Foundation team gathered from lectures, posters, and panel discussions at the conference.

A new study conducted by researchers at the Cleveland Clinic and presented at the recent American College of Gastroenterology (ACG) meeting is shedding light on just how deeply celiac disease can impact a woman’s reproductive system.

Chugai Pharmaceutical Co., Ltd. recently published encouraging results from a non-clinical study on DONQ52, an experimental medication for celiac disease. The findings show its potential to block the immune response to gluten in celiac disease without affecting the rest of the immune system.  

Otorhinolaryngological (ORL) – better known as ear, nose, and throat – complaints in celiac disease are considered rare and are often overlooked by physicians. A recent international narrative review analyzed the latest evidence on the association among celiac disease, ORL, and esophageal symptoms. 

A recent international study co-authored by Celiac Disease Foundation grant award winner Dr. Benjamin Lebwohl aimed to assess the effectiveness of the Pfizer COVID-19 vaccine in patients with celiac disease. Results revealed that the Pfizer COVID-19 vaccine offers the same level of protection against the virus for patients with celiac disease as it does for those without the autoimmune disease.

A recent study published in The Lancet Journal of Gastroenterology & Hepatology sought to determine the accuracy of blood (serological) tests in celiac disease diagnosis in adults. The results of this study are interesting, to say the least.

The Cribsiders Podcast on pediatric medicine recently released an episode with a special guest, Dr. Dale Lee from Seattle Children's Hospital, about the diagnosis and management of celiac disease.